Reaction
Connective Tissue Disease-Associated Interstitial Lung Disease reporting signals
As of the last recalculation, Connective Tissue Disease-Associated Interstitial Lung Disease appears in 50 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 473.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Baricitinib | 9 | 473.7 | 474.1 |
| Nintedanib | 13 | 232.8 | 232.9 |